PR Newswire (press release) On June 3, 2013, NewLink Genetics Corporation (NewLink Genetics) announced results from a Phase 2 clinical study with its drug candidate algenpantucel-L. The study evaluated algenpantucel-L plus standard-of-care adjuvant therapy ( gemcitabine and ... and more »
The Oncology Report Median overall survival was 7.9 months for gemcitabine (Gemzar) and capecitabine (Xeloda) chemotherapy alone, 6.9 months for 8 weeks of gemcitabine and capecitabine followed by GV1001 vaccinations until progressive disease then gemcitabine and ...
Medscape The committee looked at 2 disease states — metastatic pancreatic cancer and locally advanced disease — and 2 treatments — FOLFIRONOX (irinotecan, oxaliplatin, leucovorin, and 5-fluorouracil) and gemcitabine . It is recommended that clinical trials ... and more »
Seeking Alpha OGX-225 is a second generation antisense drug candidate designed to inhibit the production of Insulin Growth Factor Binding Proteins -2 and -5 (IGFBP-2, IGFBP-5), two proteins that when overexpressed affect the growth of cancer cells. Increased IGFBP-2 ...
MetroNews Canada The bids do not include the cost of the drugs in question — cyclophosphamide and gemcitabine — which are commonly used to treat cancers of the breast and lymphatic system. Asked by Tory MPP Jane McKenna to account for the “huge difference in pricing ... and more »
PMLiVE ... metastatic NSCLC, other than predominantly squamous cell histology if disease has not progressed immediately following platinum-based chemotherapy in combination with Lilly's other cancer drug Gemzar ( gemcitabine ), or chemotherapy drugs paclitaxel ...
Windsor Star The Star filed formal requests with the five hospitals that received cyclophosphamide and gemcitabine from Marchese Hospital Solutions under freedom of information laws. Ontario hospitals became subject to the Freedom of Information and Protection of ... and more »
The Oncology Report Median overall survival was 7.9 months for gemcitabine (Gemzar) and capecitabine (Xeloda) chemotherapy alone, 6.9 months for 8 weeks of gemcitabine and capecitabine followed by GV1001 vaccinations until progressive disease then gemcitabine and ...
